{"SLR NAME":"Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
A Systematic Review and Meta-analysis","References":[{"title1":"Ramipril in High-Risk Patients With COVID-19","References":[{"title2":"Coronaviruses as the cause of respiratory infections","References":[{"title3":"Treatment of middle east respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Viral shedding and antibody response in 37 patients with middle east respiratory syndrome Coronavirus infection"},{"title3":"Hosts and sources of endemic human Coronaviruses"},{"title3":"Transmission of MERS-coronavirus in household contacts"},{"title3":"Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients"},{"title3":"Human coronaviruses are uncommon in patients with gastrointestinal illness"},{"title3":"Human Coronavirus infections in Israel: epidemiology, clinical symptoms and summer seasonality of HcoV-HKU1"},{"title3":"Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission"},{"title3":"Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017"},{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004"},{"title3":"Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL"},{"title3":"The WHO R&amp;D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts"},{"title3":"Human Coronavirus OC43 associated with fatal encephalitis"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Commonly circulating human coronaviruses do not have a significant role in the etiology of gastrointestinal infections in hospitalized children"},{"title3":"RKI (2014) Empfehlungen des RKI fur das Management von Kontaktpersonen laborbestatigter symptomatischer MERS-Falle; Stand 3. Juli 2014. In, Berlin https://www.rki.de/DE/Content/InfAZ/M/MERS_Coronavirus/MERS-CoV_Management_Kontaktpersonen.html"},{"title3":"Asymptomatic summertime shedding of respiratory viruses"},{"title3":"Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction"},{"title3":"WHO (2004) Severe acute respiratory syndrome (SARS) - Disease outbreak news, May 2004. In: https://www.who.int/csr/sars/archive/en/"},{"title3":"WHO (2019) Middle East respiratory syndrome coronavirus (MERS-CoV) - MERS situation update, April 2019. In: https://www.who.int/emergencies/mers-cov/en/"},{"title3":"Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Countrywide survey for MERS-Coronavirus antibodies in dromedaries and humans in Pakistan"}]},{"title2":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003","References":[{"title3":"Epidemiological study on severe acute respiratory syndrome in Guangdong province"},{"title3":"Guangdong Public Health Office. 2003: Document No 2. Summary report of investigating an atypical pneumonia outbreak in Zhongshan (January 21, 2003)."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Update: outbreak of severe acute respiratory syndrome-Worldwide, 2003"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR"},{"title3":"MEGA2: molecular evolutionary genetics analysis software"},{"title3":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses"},{"title3":"RNA virus mutations and fitness for survival"},{"title3":"A pandemic warning?"},{"title3":"Characterisation of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness"},{"title3":"An influenza epicentre?"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/country/2003_07_03. Accessed 8 July 2003."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases"},{"title3":"Hypothesis: ACE2 modulates blood pressure in the mammalian organism"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS"},{"title3":"HIV-1 subtype and second-receptor use"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","References":[]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"COVID-19 and the cardiovascular system [published ahead of print]."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for Covid-19 infection? [published online ahead of print]."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2."},{"title3":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor [published ahead of print]."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Ang II (Angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent."},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis."},{"title3":"Renal ACE2 expression in human kidney disease."},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase."},{"title3":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy."},{"title3":"Counterregulatory actions of angiotensin-(1-7)."},{"title3":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure."},{"title3":"Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension."},{"title3":"Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease."},{"title3":"Classic and nonclassic renin-angiotensin systems in the critically ill."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice."},{"title3":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan."},{"title3":"Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis."},{"title3":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism."},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? [published ahead online]"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics [published online ahead of print]."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure."},{"title3":"Angiotensin receptor antagonists: safety and tolerability profile."},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)."},{"title3":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers."}]},{"title2":"Angiotensin converting enzyme 2: a double-edged sword","References":[{"title3":"Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P et al (2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. GeroScience.:1-29"},{"title3":"Clinical implications of SARS-Cov2 interaction with renin angiotensin system"},{"title3":"Rahimi F, Abadi ATB (2020) Challenges of managing the asymptomatic carriers of SARS-CoV-2. Travel Med Infect Dis 101677. 10.1016/j.tmaid.2020.101677"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 productively infects human gut enterocytes"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection"},{"title3":"Guo J, Wei X, Li Q, Li L, Yang Z, Shi Y, Qin Y, Zhang X, Wang X, Zhi X, Meng D (2020) Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury. J Cell Physiol. 10.1002/jcp.29802"},{"title3":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients"},{"title3":"Gattinoni L, Chiumello D, Rossi S (2020) COVID-19 pneumonia: ARDS or not? Crit Care 24:154. 10.1186/s13054-020-02880-z"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, Galante D, Golino P, Nigro G (2020) Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol 76:138-145. 10.1097/FJC.0000000000000854"},{"title3":"Iba T, Levy JH, Levi M, Connors JM, Thachil J Coagulopathy of coronavirus disease 2019. Crit Care Med:2020"},{"title3":"Yang C, Jin Z (2020) An acute respiratory infection runs into the most common noncommunicable epidemic:COVID-19 and cardiovascular diseases. JAMA Cardiol 5:743. 10.1001/jamacardio.2020.0934"},{"title3":"Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction"},{"title3":"Inflammatory differences in plaque erosion and rupture in patients with ST-segment elevation myocardial infarction"},{"title3":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Mitochondrial angiotensin receptors and cardioprotective pathways"},{"title3":"Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system"},{"title3":"Rethinking the renin-angiotensin system and its role in cardiovascular regulation"},{"title3":"Angiotensin converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and diastolic dysfunction"},{"title3":"The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure"},{"title3":"Angiotensin II and nitric oxide interaction"},{"title3":"Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease"},{"title3":"Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation"},{"title3":"Gene silencing of endothelial von Willebrand factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells"},{"title3":"Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors"},{"title3":"Bradykinin-mediated angioedema"},{"title3":"Pattern of hospitalizations for angioedema in New York between 1990 and 2003"},{"title3":"Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N (2020) Effect of renin-angiotensin system inhibition on cardiac structure and function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Heart Fail Rev:1-8"},{"title3":"Gene therapy with angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction"},{"title3":"Role of ACE2 in diastolic and systolic heart failure"},{"title3":"Ferrario CM, Trask AJ, Jessup JA (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Phys Heart Circ Phys 289(6):H2281-H2H90. 10.1152/ajpheart.00618.2005"},{"title3":"ACE2, angiotensin-(1-7) and M as receptor axis in inflammation and fibrosis"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Effects of inhibitors of the renin-angiotensin system on reducing blood pressure and expression of inflammatory factors in CHD patients: a network meta-analysis"},{"title3":"Plasma bradykinin in angio-oedema"},{"title3":"Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor-associated angioedema"},{"title3":"Unraveling the pivotal role of bradykinin in ACE inhibitor activity"},{"title3":"Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE"},{"title3":"Effects of antihypertensive drugs on endothelial dysfunction"},{"title3":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction"},{"title3":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease"},{"title3":"Hypotension in transgenic mice overexpressing human bradykinin B2 receptor"},{"title3":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme"},{"title3":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats"},{"title3":"Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan"},{"title3":"ACE inhibitor-induced angioedema: a review"},{"title3":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients"},{"title3":"Circulating plasma concentrations of ACE2 in men and women with heart failure and effects of renin-angiotensin-aldosterone-inhibitors"},{"title3":"The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction"},{"title3":"Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway"},{"title3":"Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis"},{"title3":"Angiotensin II formation and endothelin clearance in ARDS patients in supine and prone positions"},{"title3":"Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X et al (2018) A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur Respir J 51(6)"},{"title3":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics"},{"title3":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43):33238-33243"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Angiotensin-converting enzyme: zinc-and inhibitor-binding stoichiometries of the somatic and testis isozymes"},{"title3":"Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Structural basis of receptor recognition by SARS-CoV-2"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 436(7047):112-116. 10.1038/nature03712"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 European Society of Hypertension COVID-19 Task Force Review of Evidence"},{"title3":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. In: Maier H., Bickerton E., Britton P. (eds) Coronaviruses. Methods in Molecular Biology, vol 1282. Humana Press, New York, NY. 10.1007/978-1-4939-2438-7_1"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension"},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers"},{"title3":"Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis"},{"title3":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells"},{"title3":"Joint HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al (2020) SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 41:1801-3. 10.1093/eurheartj/ehaa235."},{"title3":"Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure"},{"title3":"Lionetti V, Barile L (2019) Perioperative cardioprotection: back to bedside. Minerva Anestesiol 86:445-54. 10.23736/S0375-9393.19.13848-5"}]},{"title2":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Estimation of risk factors for COVID-19 mortality:preliminary results"},{"title3":"Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016"},{"title3":"Case definition and European surveillance for COVID-19, as of 2 March 2020"},{"title3":"Coronavirus disease 2019 and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection"},{"title3":"Sex differences in the aging pattern of renin-angiotensin system serum peptidases"},{"title3":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling"},{"title3":"ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7)"},{"title3":"The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function"},{"title3":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats"},{"title3":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors"},{"title3":"New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure"},{"title3":"Circulating ACE2 activity correlates with cardiovascular disease development"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Clinical risks for development of the acute respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2:a new cardiac regulator"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2"},{"title3":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome"},{"title3":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis"},{"title3":"Male-female differences in fertility and blood pressure in ACE-deficient mice"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study"},{"title3":"Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Consequences of alteration in capillary permeability"},{"title3":"Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure"},{"title3":"PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide"},{"title3":"Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"}]},{"title2":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","References":[{"title3":"Characteristics of and important Lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 cases from the Chinese Center for disease control and Prevention"},{"title3":"Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Recent Update of renin-angiotensin-aldosterone"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on short-Term mortality After sepsis: a population-based aohort study"},{"title3":"Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA"},{"title3":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway"},{"title3":"Beta Blocker and angiotensin-converting enzyme Inhibitor therapy Is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure"}]},{"title2":"Renin-angiotensin system inhibition following transcatheter aortic valve replacement","References":[]},{"title2":"Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study","References":[{"title3":"Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample"},{"title3":"Fourth ECATS Adult Cardiac Surgical Database Report: towards global benchmarking"},{"title3":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery"},{"title3":"Transcatheter versus surgical aortic-valve replacement in high-risk patients"},{"title3":"Transcatheter aortic-valve replacement with a self-expanding prosthesis"},{"title3":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients"},{"title3":"2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement"},{"title3":"Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry"},{"title3":"Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis"},{"title3":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis"},{"title3":"Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts"},{"title3":"Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease"},{"title3":"Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice"},{"title3":"Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure"},{"title3":"Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies"},{"title3":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients"},{"title3":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)"},{"title3":"Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy"},{"title3":"Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study"},{"title3":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)"},{"title3":"Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis"},{"title3":"Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis"},{"title3":"Predictable changes in left ventricular mass and function during ten years after valve replacement for aortic stenosis"},{"title3":"Preoperative moderate to severe diastolic dysfunction: a novel Doppler echocardiographic long-term prognostic factor in patients with severe aortic stenosis"},{"title3":"Improved prognosis following renin-angiotensin-aldosterone system blockade in patients undergoing concomitant aortic and mitral valve replacement"},{"title3":"Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study"},{"title3":"Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis"},{"title3":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients"},{"title3":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document"},{"title3":"Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study"},{"title3":"Incidence, causes, and predictors of early (&lt;=30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement"},{"title3":"Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation"}]},{"title2":"Coronavirus Disease 2019: Situation Report-76. April 5, 2020","References":[]},{"title2":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","References":[]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases"}]},{"title2":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","References":[{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID- 19 pandemic?"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension?"},{"title3":"Effects of sodium glucose co-transporter 2 inhibitors on the kidney"},{"title3":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats"},{"title3":"Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease"}]},{"title2":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"HFSA/ACC/AHA Statement Addressed Concerns Re: Using RAAS Antagonists in COVID-19","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 states, March 1-30, 2020","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"The US Influenza Hospitalization Surveillance Network."},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020."},{"title3":"Estimating influenza disease burden from population-based surveillance data in the United States."}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","References":[]},{"title2":"Obesity and its implications for COVID-19 mortality","References":[{"title3":"Modeling and prediction of the 2019 coronavirus disease spreading in China incorporating human migration data"},{"title3":"Using reports of symptoms and diagnoses on social media to predict COVID-19 case counts in mainland China: observational infoveillance study"},{"title3":"Coronavirus disease (COVID-19) situation report - 165"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Mapping of health literacy and social panic via web search data during the COVID-19 public health emergency: infodemiological study"},{"title3":"Impact of nutrition and diet on COVID-19 infection and implications for kidney health and kidney disease management"},{"title3":"Protecting older people from COVID-19: should the United Kingdom start at age 60?"},{"title3":"Identification of symptoms prognostic of COVID-19 severity: multivariate data analysis of a case series in Henan Province"},{"title3":"The impact of nutrition on COVID-19 susceptibility and long-term consequences"},{"title3":"Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol"},{"title3":"Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017"},{"title3":"Nutritional recommendations for CoVID-19 quarantine"},{"title3":"Potential interventions for novel coronavirus in China: a systematic review"},{"title3":"Clinical definition of overweight and obesity"},{"title3":"Role of health care expenditure in countering adverse effects of obesity on health: evidence from global data"},{"title3":"FAO/WHO GIFT (Global Individual Food Consumption Data Tool): a global repository for harmonised individual quantitative food consumption studies"},{"title3":"COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University"},{"title3":"Reported cases and deaths by country, territory, or conveyance"},{"title3":"FAOSTAT: FAO statistical database"},{"title3":"Some statistical models for limited dependent variables with application to the demand for durable goods"},{"title3":"A two-part model of the demand for medical care : preliminary results from the Health Insurance Study"},{"title3":"A comparison of alternative models for the demand for medical care"},{"title3":"A new regression model for positive data"},{"title3":"A marginalized two-part model for semicontinuous data"},{"title3":"A zero-inflated spatial gamma process model with applications to disease mapping"},{"title3":"Marginalized two part models for generalized gamma family of distributions"},{"title3":"Use of log-skew-normal distribution in analysis of continuous data with a discrete component at zero"},{"title3":"Some generalized functions for the size distribution of income"},{"title3":"A three-level mixed-effects location scale model with an application to ecological momentary assessment data"},{"title3":"A multi-level two-part random effects model, with application to an alcohol-dependence study"},{"title3":"Analysis of repeated measures data with clumping at zero"},{"title3":"Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease"},{"title3":"Obesity and its implications for COVID-19 mortality"},{"title3":"COVID-19 and obesity"},{"title3":"Risk of COVID-19 for patients with obesity"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission"}]},{"title2":"COVID-19 and endocrine diseases: a statement from the European Society of Endocrinology","References":[{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"M. Ackermann et al. pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J.Med. (2020) 10.1056/NEJMoa2015432"},{"title3":"COVID-19 and endocrine diseases. A statement from the european society of endocrinology"},{"title3":"Endocrine and metabolic aspects of the COVID-19 pandemic"},{"title3":"Z. Wu, J. M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA (2020). 10.1001/jama.2020.2648"},{"title3":"S. Q. Deng, H. J. Peng, Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J. Clin. Med. 9 (2020). 10.3390/jcm9020575"},{"title3":"Infections in patients with diabetes mellitus: a review of pathogenesis"},{"title3":"J. J. Zhang, X. Dong, Y. Y. Cao, Y. D. Yuan, Y. B. Yang, Y. Q. Yan, C.A. Akdis, Y. D. Gao. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy (2020) 10.1111/all.14238"},{"title3":"D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong, Y. Zhao, Y. Li, X. Wang, Z. Peng, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA (2020). 10.1001/jama.2020.1585"},{"title3":"M. A. Hill, C. Mantzoros, J. R. Sowers, Commentary: COVID-19 in patients with diabetes. Metab. Clin. Exp. 154217 (2020). 10.1016/j.metabol.2020.154217"},{"title3":"Sexual dimorphism of coronavirus 19 morbidity and lethality"},{"title3":"Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis"},{"title3":"Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Deep phenotyping of 34,128 patients hospitalized with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study"},{"title3":"en nombre del Grupo SEMI-COVID-19 Network. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry"},{"title3":"H. Lee, J. R. Lee, H. Jung, J. Y. Lee, Power of universal health coverage in the era of COVID-19: a nationwide observational study. Lancet Reg. Health West. Pac. 100088 (2021). 10.1016/j.lanwpc.2020.100088"},{"title3":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"},{"title3":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States"},{"title3":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes"},{"title3":"CORONADO investigators. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study"},{"title3":"L. Masana, E. Correig, C. Rodriguez-Borjabad, E. Anoro, J. A. Arroyo, C. Jerico, A. Pedragosa, M. Miret, S. Naf, A. Pardo, V. Perea, R. Perez-Bernalte, N. Plana, R. Ramirez-Montesinos, M. Royuela, C. Soler, M. Urquizu-Padilla, A. Zamora, J. Pedro-Botet, Group OBOTSR. EFFECT oF STATIN THERAPY oN SARS-CoV-2 INFECTION-RELATED. Eur. Heart J. Cardiovasc. Pharmacother. pvaa128 (2020). 10.1093/ehjcvp/pvaa128"},{"title3":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study."},{"title3":"Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia"},{"title3":"Factors determining the appearance of glucose in upper and lower respiratory tract secretions"},{"title3":"Serum surfactant protein D as a biomarker for measuring lung involvement in obese patients with type 2 diabetes"},{"title3":"Pulmonary function and sleep breathing: two new targets for type 2 diabetes care"},{"title3":"W. Guo, M. Li, Y. Dong, H. Zhou, Z. Zhang, C. Tian, R. Qin, H. Wang, Y. Shen, K. Du, L. Zhao, H. Fan, S. Luo, D. Hu, Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab. Res. Rev. e3319 (2020). 10.1002/dmrr.3319"},{"title3":"L. Chen, W. Sun, Y. Liu, L. Zhang, Y. Lv, Q. Wang, D. Long, Y. Wang, S. Zhao, S. Rong, L. Yu, L. Liu, Association of early-phase in-hospital glycemic fluctuation with mortality in adult patients with coronavirus disease 2019. Diabetes Care. (2021). 10.2337/dc20-0780"},{"title3":"Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA"},{"title3":"New-onset diabetes in Covid-19"},{"title3":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes"},{"title3":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study"},{"title3":"A. Corcillo, S. Cohen, A. Li, J. Crane, D. Kariyawasam, J. Karalliedde, Diabetic retinopathy is independently associated with increased risk of intubation: a single centre cohort study of patients with diabetes hospitalised with COVID-19. Diabetes Res. Clin. Pract. 108529 (2020). 10.1016/j.diabres.2020.108529"},{"title3":"Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors"},{"title3":"The natural history of symptomatic COVID-19 during the first wave in Catalonia"},{"title3":"Prevalence of obesity and its impact on outcome in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Coronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysis"},{"title3":"Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry"},{"title3":"Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: comparisons with influenza/pneumonia and coronary heart disease"},{"title3":"Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection"},{"title3":"M. Wolf, J. Alladina, A. Navarrete-Welton, B. Shoults, K. Brait, D. Ziehr, A. Malhotra, C. C. Hardin, K. A. Hibbert, Obesity and critical illness in COVID-19: respiratory pathophysiology. Obesity (Silver Spring) (2021). 10.1002/oby.23142"},{"title3":"G. Halasz, M. L. Leoni, G. Q. Villani, M. Nolli, M. Villani, Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy. Eur. J. Prev. Cardiol. 2047487320939675 (2020). 10.1177/2047487320939675"},{"title3":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)"},{"title3":"Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding"},{"title3":"Susceptibility of the obese population to COVID-19"},{"title3":"ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection"},{"title3":"Clinical Nutrition in times of COVID-19"},{"title3":"ESPEN guidelines on nutritional support for polymorbid internal medicine patients"},{"title3":"ESPEN guideline on clinical nutrition and hydration in geriatrics"},{"title3":"Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China"},{"title3":"Clinical significance of nutritional risk screening for older adult patients with COVID-19"},{"title3":"A. Ramos, C. Joaquin, M. Ros, M. Martin, M. Cachero, M. Sospedra, E. Martinez, M.J. Sendros, J.M. Sanchez-Migallon, M. Puig-Domingo, Nutritional support in COVID -19 patients 60th Congress of the Spanish Society of Endocrinology and Nutrition 2021 (Oral Communication)"},{"title3":"S. Nampoothiri, F. Sauve, G. Ternier, D. Fernandois, C. Coelho, M. Imbernon et al. The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis. bioRxiv. (2020). 10.1101/2020.06.08.139329"},{"title3":"Low levels of total and ionized calcium in blood of COVID-19 patients"},{"title3":"Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19"},{"title3":"L. di Filippo, A. M. Formenti, M. Doga, S. Frara, P. Rovere-Querini, E. Bosi, M. Carlucci, A. Giustina, Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine 1-5 (2020). 10.1007/s12020-020-02541-9"},{"title3":"F. Cappellini, R. Brivio, M. Casati, A. Cavallero, E. Contro, P. Brambilla, Low levels of total and ionized calcium in blood of COVID-19 patients. Clin. Chem. Lab. Med. (2020)."},{"title3":"Prevalence and predictive value of hypocalcemia in severe COVID-19 patients"},{"title3":"Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019"},{"title3":"Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells"},{"title3":"Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area"},{"title3":"Controversies in vitamin D: summary statement from an international conference"},{"title3":"Treatment of hypoparathyroidism"},{"title3":"Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism"},{"title3":"Controversies in vitamin D: a statement from the third international conference"},{"title3":"A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency"},{"title3":"COVID-19 fatalities, latitude, sunlight, and vitamin D"},{"title3":"Consensus statement from 2nd international conference on controversies in vitamin D"},{"title3":"Vitamin D and critical illness outcomes"},{"title3":"Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data"},{"title3":"Mechanisms in endocrinology: vitamin D and COVID-19"},{"title3":"Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D"},{"title3":"A. Giustina, Hypovitaminosis D and the endocrine phenotype of COVID-19. Endocrine. 1-11 (2021). 10.1007/s12020-021-02671-8"},{"title3":"D. De Smet, K. De Smet, P. Herroelen, S. Gryspeerdt, G. A. Martens, Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality. Am. J. Clin. Pathol. aqaa252 (2020). 10.1093/ajcp/aqaa252"},{"title3":"&quot;Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study&quot;"},{"title3":"F.M. Ulivieri, et al. Vitamin D in the COVID-19 era: a review with recommendations from A G.I.O.S.E.G expert panel. Endocrine 2021 (in press)"},{"title3":"Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes"},{"title3":"Are women with osteoporosis treated with denosumab at risk of severe COVID-19?"},{"title3":"Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)"},{"title3":"Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?"},{"title3":"Molecular mimicry of ACTH in SARS:implications for corticosteroid treatment and prophylaxis"},{"title3":"COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency"},{"title3":"Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality"},{"title3":"Endocrinology in the time of COVID-19: Management of adrenal insufficiency"},{"title3":"Adrenal insufficiency at the time of COVID-19: a retrospective study in patients referring to a tertiary center"},{"title3":"Bone safety of dual-release hydrocortisone in patients with hypopituitarism"},{"title3":"Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines"},{"title3":"J. Newell-Price, L. Nieman, M. Reincke, A. Tabarin, Endocrinology in the time of COVID-19: management of cushing's syndrome. Eur. J. Endocrinol. (2020) https://eje.bioscientifica.com/view/journals/eje/aop/eje-20-0352/eje-20-0352.xml"},{"title3":"MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects"},{"title3":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol"},{"title3":"A. L. Serban, E. Ferrante, G. Carosi, R. Indirli, M. Arosio, G. Mantovani, COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy. J. Endocrinol. Investig. 1-2 (2020). 10.1007/s40618-020-01419-x"},{"title3":"S. Frara, A. Allora, L. Castellino, L. di Filippo, P. Loli, A. Giustina, Covid-19 and the pituitary. Pituitary. (2021) (submitted). 10.1007/s11102-021-01148-1"},{"title3":"COVID-19 and the endocrine system: exploring the unexplored"},{"title3":"The changing clinical spectrum of hypophysitis"},{"title3":"W. Wang, X. Su, Y. Ding, W. Fan, J. Su, Z. Chen et al. Thyroid function abnormalities in COVID-19 patients. medRxiv. (2020). 10.1101/2020.06.15.20130807"},{"title3":"Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era"},{"title3":"Current and emerging aspects of diabetes mellitus in acromegaly"},{"title3":"A. Giustina, A. Barkan, A. Beckers, N. Biermasz, B. M. K. Biller, C. Boguszewski, M. Bolanowski, V. Bonert, M. D. Bronstein, F. F. Casanueva, D. Clemmons, A. Colao, D. Ferone, M. Fleseriu, S. Frara, M. R. Gadelha, E. Ghigo, M. Gurnell, A. P. Heaney, K. Ho, A. Ioachimescu, L. Katznelson, F. Kelestimur, J. Kopchick, M. Krsek, S. Lamberts, M. Losa, A. Luger, P. Maffei, M. Marazuela, G. Mazziotti, M. Mercado, P. Mortini, S. Neggers, A. M. Pereira, S. Petersenn, M. Puig-Domingo, R. Salvatori, I. Shimon, C. Strasburger, S. Tsagarakis, A. J. van der Lely, J. Wass, M. C. Zatelli, S. Melmed, A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J. Clin. Endocrinol. Metab. 105(4) (2020). 10.1210/clinem/dgz096"},{"title3":"Diabetes in cushing disease"},{"title3":"A. Giustina, Pituitary adenomas....nomen omen? Eur. J. Endocrinol. (2021 in press)"},{"title3":"Letter: the risk of COVID-19 infection during neurosurgical procedures: a review of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) modes of transmission and proposed neurosurgery-specific measures for mitigation"},{"title3":"Pituitary surgery during Covid-19: a first hand experience and evaluation"},{"title3":"P. Tzoulis, J. A. Waung, E. Bagkeris, Z. Hussein, A. Biddanda, J. Cousins, A. Dewsnip, K. Falayi, W. McCaughran, C. Mullins, A. Naeem, M. Nwokolo, H. Quah, S. Bitat, E. Deyab, S. Ponnampalam, P. M. Bouloux, H. Montgomery, S. E. Baldeweg, Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19. J. Clin. Endocrinol. Metab. (2021). 10.1210/clinem/dgab10"},{"title3":"Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?"},{"title3":"A. Fernandez Martinez, D. Barajas Galindo, J. Ruiz Sanchez, Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: a consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group). Rev. Endocr. Metab. Disord. (2021). 10.1007/s11154-021-09627-3"},{"title3":"ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"SARS-CoV-2-related atypical thyroiditis"},{"title3":"Subacute thyroiditis after Sars-COV-2 infection"},{"title3":"COVID-19: a cause of recurrent Graves' hyperthyroidism?"},{"title3":"Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism"},{"title3":"A. Vrachimis, I. Iacovou, E. Giannoula, L. Giovanella, Endocrinology in the time of COVID-19: management of thyroid nodules and cancer. Eur. J. Endocrinol. EJE-20-0269.R2 (2020). 10.1530/EJE-20-0269"},{"title3":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission"},{"title3":"J. Bergman, M. Ballin, A. Nordstrom, P. Nordstrom, Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur. J. Epidemiol. 1-12 (2021). 10.1007/s10654-021-00732-w"},{"title3":"An assessment on Impact of COVID-19 infection in a gender specific manner"},{"title3":"Who is wearing a mask? Gender-, age-, and location-related differences during the COVID-19 pandemic"},{"title3":"Sex and gender: modifiers of health, disease, and medicine"},{"title3":"P. R. Ebeling, R. A. Adler, G. Jones, U. A. Liberman, G. Mazziotti, S. Minisola, C. F. Munns, N. Napoli, A. G. Pittas, A. Giustina, J. P. Bilezikian, R. Rizzoli, MANAGEMENT OF ENDOCRINE DISEASE: Therapeutics of vitamin D. Eur. J. Endocrinol. R239-R259 (2018). 10.1530/EJE-18-0151"},{"title3":"Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2"},{"title3":"ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19"},{"title3":"Sex differences in immune responses"},{"title3":"T. Takahashi, M.K. Ellingson, P. Wong, B. Israelow, C. Lucas, J. Klein, J. Silva, T. Mao, J.E. Oh, M. Tokuyama, P. Lu, A. Venkataraman, A. Park, F. Liu, A. Meir, J. Sun, E.Y. Wang, A. Casanovas-Massana, A.L. Wyllie, C.B.F. Vogels, R. Earnest, S. Lapidus, I.M. Ott, A.J. Moore, Yale IMPACT Research Team, A. Shaw, J. B. Fournier, C. D. Odio, S. Farhadian, C. Dela Cruz, N. D. Grubaugh, W. L. Schulz, A. M. Ring, A. I. Ko, S. B. Omer, A. Iwasaki, Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588 (7837), 315-320 (2020). 10.1038/s41586-020-2700-3"},{"title3":"Male balding is a major risk factor for severe COVID-19"},{"title3":"Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The &quot;Gabrin sign&quot;"},{"title3":"Effects of medical treatment of prostate cancer on bone health"},{"title3":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)"},{"title3":"Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to-remission in males with COVID-19: a randomized, double-blind, placebo-controlled interventional trial (EAT-DUTA AndroCoV Trial:Biochemical)"},{"title3":"Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial."},{"title3":"Italian Study Group on Geriatric Endocrinology. Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men"},{"title3":"A. Luger, A. Giustina, R. Peeters, European Society of Endocrinology (ESE)'s statement concerning COVID19 vaccination: 'follow the same recommendations for patients with stable endocrine disorders as for the general population www-ese-hormones.org"},{"title3":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine"},{"title3":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine"},{"title3":"L. Katznelson, M. Gadelha, Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement. Pituitary. (2021). 10.1007/s11102-021-01130-x"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction"},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial"},{"title3":"2018 ESC/ESH Guidelines for the management of arterial hypertension"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC"},{"title3":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group"},{"title3":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group"},{"title3":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction"},{"title3":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study"}]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","References":[{"title3":"Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 States, March 1-30, 2020"},{"title3":"Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection"},{"title3":"Drugs and the renin-angiotensin system in covid-19"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study"},{"title3":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study"},{"title3":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality"},{"title3":"Coronavirus disease 2019 and hypertension: the role of angiotensin-converting enzyme 2 and the renin-angiotensin system"},{"title3":"Good ACE, bad ACE do battle in lung injury, SARS"},{"title3":"Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19"},{"title3":"Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure"},{"title3":"The expanding role of real-world evidence trials in health care decision making"},{"title3":"Real world evidence (RWE):are we (RWE) ready?"}]}]},{"title1":"Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"An interactive web-based dashboard to track COVID-19 in real time","References":[{"title3":"WHO statement regarding cluster of pneumonia cases in Wuhan, China"},{"title3":"Coronavirus disease 2019 (COVID-19) situation reports"},{"title3":"Tracking the epidemic"}]},{"title2":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease","References":[{"title3":"Early statin use is an independent predictor of long-term graft survival"},{"title3":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization"},{"title3":"Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study"},{"title3":"The importance of the intrarenal renin-angiotensin system"},{"title3":"Effect of 6-nonadecyl salicylic acid and its methyl ester on the induction of micronuclei in polychromatic erythrocytes in mouse peripheral blood"},{"title3":"Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas"},{"title3":"Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice"},{"title3":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis"},{"title3":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice"},{"title3":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study"},{"title3":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor"},{"title3":"Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications"},{"title3":"Circulating angiotensin-converting enzyme 2 activity in kidney transplantation: a longitudinal pilot study"},{"title3":"Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease"},{"title3":"Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study"},{"title3":"[Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project]"},{"title3":"Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse"},{"title3":"ACE and ACE2 activity in diabetic mice"},{"title3":"A high-throughput fluorimetric assay for angiotensin I-converting enzyme"},{"title3":"Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?"},{"title3":"Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells"},{"title3":"Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications"},{"title3":"Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction"},{"title3":"Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized With COVID-19","References":[]},{"title2":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","References":[]},{"title2":"HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. Available at:https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19. Accessed April 18, 2020.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Effects of captopril related to increased levels of prostacyclin and angiotension-(1-7) in essential hypertension","References":[]},{"title2":"ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study","References":[]},{"title2":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","References":[{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"SARS-CoV-2: a potential novel etiology of fulminant myocarditis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Renin-angiotensin system in human coronavirus pathogenesis"}]}]},{"title1":"Angiotensin?converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe <styled-content style="fixed-case" toggle="no">COVID?19</styled-content> infection in a multi?site <styled-content style="fixed-case" toggle="no">UK</styled-content> acute hospital trust","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome"},{"title3":"The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target"},{"title3":"Mechanisms of COVID-19-induced heart failure: a short review"},{"title3":"The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science"},{"title3":"Mechanisms of COVID-19 pathogenesis in diabetes"},{"title3":"Cardiac iron overload promotes cardiac injury in patients with severe COVID-19"},{"title3":"Sexual dimorphism in COVID-19: potential clinical and public health implications"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects"},{"title3":"Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?"},{"title3":"Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference"},{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Hamidi A and Olsson A K: Platelets, NETs and cancer"},{"title3":"Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"COVID-19 and Cardiovascular Disease: From Bench to Bedside"},{"title3":"A global meta-analysis of depression, anxiety, and stress before and during COVID-19"},{"title3":"COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample Database"},{"title3":"Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic"},{"title3":"COVID-19 and metabolic syndrome"},{"title3":"Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases"},{"title3":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021"},{"title3":"COVID-19, Myocarditis and Pericarditis"},{"title3":"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets"},{"title3":"Cardiometabolic syndrome:an emergent feature of Long COVID?"},{"title3":"Risk factors for severe and critically ill COVID-19 patients: A review"},{"title3":"The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"},{"title3":"Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19"},{"title3":"Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"},{"title3":"Depression and Anxiety in Old Age during the COVID-19 Pandemic: A Comparative Study of Individuals at Cardiovascular Risk and the General Population"},{"title3":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"},{"title3":"Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease"},{"title3":"Association of social relationships with incident cardiovascular events and all-cause mortality"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?"},{"title3":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases"},{"title3":"Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis"},{"title3":"Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review"},{"title3":"SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor"},{"title3":"COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors"},{"title3":"COVID-19 infection and its impact on case fatality in patients with pulmonary embolism"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review"},{"title3":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases"},{"title3":"COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis"},{"title3":"Nationwide Analysis of the Outcomes and Mortality of Hospitalized COVID-19 Patients"},{"title3":"N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients"},{"title3":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"title3":"Cardiovascular manifestations and treatment considerations in COVID-19"},{"title3":"TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation"},{"title3":"Incidence and risk factors of myocarditis in hospitalized patients with COVID-19"},{"title3":"Vascular Endothelial Cell Biology: An Update"},{"title3":"ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review"},{"title3":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2"},{"title3":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States"},{"title3":"Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis"},{"title3":"COVID-19 and cardiovascular diseases"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease"},{"title3":"Gender-based disparities in COVID-19 patient outcomes"},{"title3":"Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19"},{"title3":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients"},{"title3":"Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus"},{"title3":"TMPRSS2 activity may mediate sex differences in COVID-19 severity"},{"title3":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies"},{"title3":"Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19"},{"title3":"Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin"},{"title3":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity"},{"title3":"Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis"},{"title3":"Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury"},{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"COVID-19 and cellular senescence"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Endothelial Cell-Activating Antibodies in COVID-19"},{"title3":"COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19"},{"title3":"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1"},{"title3":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis"},{"title3":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician"},{"title3":"Identifying age- and sex-specific COVID-19 mortality trends over time in six countries"},{"title3":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility"},{"title3":"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones"},{"title3":"The bi-directional association between loneliness and depression among older adults from before to during the COVID-19 pandemic"},{"title3":"Inflammation: Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling"},{"title3":"Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality"},{"title3":"Acute Cardiac Events During COVID-19-Associated Hospitalizations"},{"title3":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes"},{"title3":"Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic"},{"title3":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition"},{"title3":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Neutrophil extracellular traps in COVID-19. JCI"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction"},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial"},{"title3":"2018 ESC/ESH Guidelines for the management of arterial hypertension"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC"},{"title3":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group"},{"title3":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group"},{"title3":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction"},{"title3":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study"}]},{"title2":"COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","References":[{"title3":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Potential effects of coronaviruses on the cardiovascular system: a review"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease"},{"title3":"The science underlying COVID-19: implications for the cardiovascular system"},{"title3":"Coronaviruses and the cardiovascular system: acute and long-term implications"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Covid-19 in critically ill patients in the Seattle region - case series"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Acute myocardial injury is common in patients with covid-19 and impairs their prognosis"},{"title3":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis"},{"title3":"End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock"},{"title3":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"An experimental model for dilated cardiomyopathy after rabbit coronavirus infection"},{"title3":"COVID-19-related myocarditis in a 21-year-old female patient"},{"title3":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?"},{"title3":"Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement"},{"title3":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"},{"title3":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects"},{"title3":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease"},{"title3":"Cardiovascular complications and short-term mortality risk in community-acquired pneumonia"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Mechanisms of cardiac and renal dysfunction in patients dying of sepsis"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study"},{"title3":"Treating oxidative stress in heart failure: past, present and future"},{"title3":"Harnessing CAR T-cell insights to develop treatments for hyperinflammatory responses in patients with COVID-19"},{"title3":"Description and proposed management of the acute COVID-19 cardiovascular syndrome"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Structural basis of receptor recognition by SARS-CoV-2"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis"},{"title3":"COVID-19, ACE2, and the cardiovascular consequences"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats"},{"title3":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction"},{"title3":"Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Drugs and the renin-angiotensin system in covid-19"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection"},{"title3":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"}]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"COVID-19 and the cardiovascular system [published ahead of print]."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for Covid-19 infection? [published online ahead of print]."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2."},{"title3":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor [published ahead of print]."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Ang II (Angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent."},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis."},{"title3":"Renal ACE2 expression in human kidney disease."},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase."},{"title3":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy."},{"title3":"Counterregulatory actions of angiotensin-(1-7)."},{"title3":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure."},{"title3":"Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension."},{"title3":"Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease."},{"title3":"Classic and nonclassic renin-angiotensin systems in the critically ill."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice."},{"title3":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan."},{"title3":"Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis."},{"title3":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism."},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? [published ahead online]"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics [published online ahead of print]."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure."},{"title3":"Angiotensin receptor antagonists: safety and tolerability profile."},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)."},{"title3":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers."}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Clinical risks for development of the acute respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2:a new cardiac regulator"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2"},{"title3":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome"},{"title3":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis"},{"title3":"Male-female differences in fertility and blood pressure in ACE-deficient mice"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study"},{"title3":"Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Consequences of alteration in capillary permeability"},{"title3":"Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure"},{"title3":"PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide"},{"title3":"Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Epidemiology Working Group. WHO consensus document on the epidemiology of severe acute respiratory syndrome (SARS). (http://www.who.int/csr/sars/en/WHOconsensus.pdf, 2003)."},{"title3":"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology"},{"title3":"Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot; influenza pandemic"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"World Health Organization. Confirmed human cases of avian influenza A (H5N1), 7 September 2004. (http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2004_09_07/en/print.html, 2004)."},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Imai, Y. et al. The SARS-coronavirus receptor angiotensin coverting enzyme 2 protects from severe acute lung failure. Nature (in the press)."},{"title3":"Chemokine receptor trafficking and viral replication"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Human coronaviruses-a brief review"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Analysis on the SARS-CoV genome of PUMC01 isolate"},{"title3":"Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation"}]},{"title2":"CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital","References":[{"title3":"An emerging standard for health communications: The HL7 standard"},{"title3":"Standardization of health informatics-results and challenges"},{"title3":"Simplifying HL7 Version 3 messages"},{"title3":"Automatic annotation of medical records"},{"title3":"Towards comprehensive syntactic and semantic annotations of the clinical narrative"},{"title3":"Applying natural language processing toolkits to electronic health records - an experience report"},{"title3":"Two biomedical sublanguages: A description based on the theories of Zellig Harris"},{"title3":"Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: Current status and recent enhancement of an Electronic Mental Health Record-derived data resource"},{"title3":"A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: A privacy-protecting remote access system for health-related research and evaluation"},{"title3":"The 100,000 Genomes Project Protocol v3, Genomics England. 2017. 10.6084/m9.figshare.4530893.v2. (from https://www.genomicsengland.co.uk/about-gecip/publications/)."},{"title3":"Moen H, Ginter F, Marsi E, Peltonen L-M, Salakoski T, Salantera S. Care episode retrieval: Distributional semantic models for information retrieval in the clinical domain. BMC Med Inform Dec Making. 2015; 15(S2)."},{"title3":"NLP-PIER: A Scalable Natural Language Processing, Indexing, and Searching Architecture for Clinical Notes"},{"title3":"The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: Development and descriptive data"},{"title3":"Kartoglu IE. Cognition: DB binary-to-text converter and pseudonymiser for clinical research. 2015. https://github.com/KHP-Informatics/Cognition-DNC."},{"title3":"Jackson R, Kartoglu I. A Open Pipeline for Masking Patient Identifiers in Electronic Health Records, The Farr Institute International Conference 2015. 2015."},{"title3":"Development and evaluation of a de-identification procedure for a case register sourced from mental health electronic records"},{"title3":"Automated concept-level information extraction to reduce the need for custom software and rules development"},{"title3":"An Overview of the Tesseract OCR Engine"},{"title3":"Negation's Not Solved: Generalizability Versus Optimizability in Clinical Natural Language Processing"},{"title3":"Evaluating natural language processors in the clinical domain"},{"title3":"The unified medical language system (UMLS): Integrating biomedical terminology"},{"title3":"Neamatullah I, Douglass MM, Lehman L-wH, Reisner A, Villarroel M, Long WJ, Szolovits P, Moody GB, Mark RG, Clifford GD. Automated de-identification of free-text medical records. BMC Med Inform Decis Mak. 2008;8(1)."},{"title3":"MIMIC-III, a freely accessible critical care database"},{"title3":"University of Sheffield. KConnect UMLS Annotation Task. 2016. http://www.dcs.shef.ac.uk/~genevieve/kconnect/annotation-manual.pdf."},{"title3":"The Human Phenotype Ontology project: Linking molecular biology and disease through phenotype data"},{"title3":"A Simple Algorithm for Identifying Negated Findings and Diseases in Discharge Summaries"},{"title3":"Automatic concept recognition using the Human Phenotype Ontology reference and test suite corpora"},{"title3":"Annotating longitudinal clinical narratives for de-identification: The 2014 i2b2/UTHealth corpus"},{"title3":"Aamot H, Kohl CD, Richter D, Knaup-Gregori P. Pseudonymization of patient identifiers for translational research. BMC Med Inform Dec Making. 2013;13(1)."},{"title3":"Crown. Anonymisation: Managing Data Protection Risk Code of Practice, Infomation Commisioners Office. 2012. https://ico.org.uk/media/1061/anonymisation-code.pdf."},{"title3":"Biomedical data privacy: Problems, perspectives, and recent advances"},{"title3":"Fifty years' development and future perspectives of psychiatric register research"},{"title3":"Secondary use of EHR: Data quality issues and informatics opportunities"},{"title3":"Consequences of impaired data quality on information retrieval in electronic patient records"},{"title3":"Developing a new model for patient recruitment in mental health services: A cohort study using Electronic Health Records"},{"title3":"Improving performance of natural language processing part-of-speech tagging on clinical narratives through domain adaptation"},{"title3":"Domain adaptation for semantic role labeling of clinical text"},{"title3":"Automated systems for the de-identification of longitudinal clinical narratives: Overview of 2014 i2b2/UTHealth shared task Track 1"}]},{"title2":"Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data","References":[{"title3":"Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study"},{"title3":"NICE. Atrial fibrillation: management (Aug 2014 update) [Internet]. 2014."},{"title3":"Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation"},{"title3":"A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey"},{"title3":"The use of anticoagulants in the management of atrial fibrillation among general practices in England"},{"title3":"A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation"},{"title3":"Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD"},{"title3":"Risk of stroke and oral anticoagulant use in atrial fibrillation: A cross-sectional survey"},{"title3":"Big data from electronic health records for early and late translational cardiovascular research: challenges and potential"},{"title3":"The Value of Unstructured Electronic Health Record Data in Geriatric Syndrome Case Identification"},{"title3":"CogStack:Experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital"},{"title3":"CogStack. CogStack Pipeline [Internet]. 2019. Available: https://github.com/CogStack/CogStack-Pipeline"},{"title3":"SemEHR: A general-purpose semantic search system to surface semantic data from clinical notes for tailored care, trial recruitment, and clinical research"},{"title3":"Wu H. CogStack-SemEHR [Internet]. p. 2019."},{"title3":"Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention"},{"title3":"Grouin C, Deleger L, Rosier A, Temal L, Dameron O, Van Hille P, et al. Automatic computation of CHA2DS2-VASc score: information extraction from clinical texts for thromboembolism risk assessment. AMIA. Annu Symp proceedings AMIA Symp. 2011;"},{"title3":"Personalized and automated remote monitoring of atrial fibrillation"},{"title3":"U.S. National Library of Medicine. Unified Medical Language System (UMLS) [Internet]. Available: https://www.nlm.nih.gov/research/umls/"},{"title3":"Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources"},{"title3":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study"},{"title3":"BioPortal: Enhanced functionality via new Web services from the National Center for Biomedical Ontology to access and use ontologies in software applications"},{"title3":"Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review"},{"title3":"Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT)"},{"title3":"Underuse of Oral Anticoagulation for Individuals with Atrial Fibrillation in a Nursing Home Setting in France: Comparisons of Resident Characteristics and Physician Attitude"},{"title3":"The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study"},{"title3":"Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study"},{"title3":"Cardiovascular Registries: Too Much of Good Thing?"},{"title3":"Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation"},{"title3":"Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry"},{"title3":"High-performance medicine: the convergence of human and artificial intelligence"}]},{"title2":"MedCAT - medical concept annotation tool","References":[]},{"title2":"MIMIC-III, a freely accessible critical care database","References":[{"title3":"Adoption of Electronic Health record Systems among U.S. Non-federal Acute Care Hospitals"},{"title3":"NIH plans to enhance reproducibility"},{"title3":"Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II): A public-access intensive care unit database"},{"title3":"Standardizing clinical laboratory data for secondary use"},{"title3":"Observational Medical Outcomes Partnership Common Data Model. Website http://www.ohdsi.org/data-standardization/the-common-data-model/(Accessed: March 2016)."},{"title3":"Automated de-identification of free-text medical records"},{"title3":"Best practices for scientific computing"},{"title3":"MIMIC-III Critical Care Database: Documentation and Website http://mimic.physionet.org (Accessed: March 2016)."},{"title3":"PhysioBank, PhysioToolkit, and PhysioNet"},{"title3":"Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension"},{"title3":"Methods of Blood Pressure Measurement in the ICU"},{"title3":"Recent Advances in Clinical Natural Language Processing in Support of Semantic Analysis"},{"title3":"Combining structured and unstructured data to identify a cohort of ICU patients who received dialysis"},{"title3":"A 'datathon' model to support cross-disciplinary collaboration"}]},{"title2":"Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package","References":[]},{"title2":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","References":[]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Physiology of local renin-angiotensin systems."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Pharmacologic modulation of ACE2 expression."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19."},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic."},{"title3":"Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients."},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China."},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19."},{"title3":"Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes."},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial."},{"title3":"Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)."},{"title3":"Coronavirus emergency."},{"title3":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension."},{"title3":"Generating evidence from computerized healthcare utilization databases."},{"title3":"Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs."},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy."}]},{"title2":"Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study","References":[]},{"title2":"Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","References":[]},{"title2":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"ACE2 gene expression is up-regulated in the human failing heart"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF"},{"title3":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Building bivariate tables: the compareGroups Package for R"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Renal ACE2 expression in human kidney disease"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Proteomics. Tissue-based map of the human proteome"},{"title3":"Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients"},{"title3":"Clinical relevance and role of neuronal AT"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease"}]},{"title2":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","References":[]}]},{"title1":"Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality","References":[{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome"},{"title3":"The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target"},{"title3":"Mechanisms of COVID-19-induced heart failure: a short review"},{"title3":"The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science"},{"title3":"Mechanisms of COVID-19 pathogenesis in diabetes"},{"title3":"Cardiac iron overload promotes cardiac injury in patients with severe COVID-19"},{"title3":"Sexual dimorphism in COVID-19: potential clinical and public health implications"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects"},{"title3":"Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?"},{"title3":"Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference"},{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Hamidi A and Olsson A K: Platelets, NETs and cancer"},{"title3":"Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"COVID-19 and Cardiovascular Disease: From Bench to Bedside"},{"title3":"A global meta-analysis of depression, anxiety, and stress before and during COVID-19"},{"title3":"COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample Database"},{"title3":"Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic"},{"title3":"COVID-19 and metabolic syndrome"},{"title3":"Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases"},{"title3":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021"},{"title3":"COVID-19, Myocarditis and Pericarditis"},{"title3":"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets"},{"title3":"Cardiometabolic syndrome:an emergent feature of Long COVID?"},{"title3":"Risk factors for severe and critically ill COVID-19 patients: A review"},{"title3":"The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"},{"title3":"Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19"},{"title3":"Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"},{"title3":"Depression and Anxiety in Old Age during the COVID-19 Pandemic: A Comparative Study of Individuals at Cardiovascular Risk and the General Population"},{"title3":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"},{"title3":"Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease"},{"title3":"Association of social relationships with incident cardiovascular events and all-cause mortality"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?"},{"title3":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases"},{"title3":"Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis"},{"title3":"Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review"},{"title3":"SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor"},{"title3":"COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors"},{"title3":"COVID-19 infection and its impact on case fatality in patients with pulmonary embolism"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review"},{"title3":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases"},{"title3":"COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis"},{"title3":"Nationwide Analysis of the Outcomes and Mortality of Hospitalized COVID-19 Patients"},{"title3":"N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients"},{"title3":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"title3":"Cardiovascular manifestations and treatment considerations in COVID-19"},{"title3":"TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation"},{"title3":"Incidence and risk factors of myocarditis in hospitalized patients with COVID-19"},{"title3":"Vascular Endothelial Cell Biology: An Update"},{"title3":"ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review"},{"title3":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2"},{"title3":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States"},{"title3":"Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis"},{"title3":"COVID-19 and cardiovascular diseases"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease"},{"title3":"Gender-based disparities in COVID-19 patient outcomes"},{"title3":"Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19"},{"title3":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients"},{"title3":"Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus"},{"title3":"TMPRSS2 activity may mediate sex differences in COVID-19 severity"},{"title3":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies"},{"title3":"Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19"},{"title3":"Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin"},{"title3":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity"},{"title3":"Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis"},{"title3":"Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury"},{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"COVID-19 and cellular senescence"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Endothelial Cell-Activating Antibodies in COVID-19"},{"title3":"COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19"},{"title3":"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1"},{"title3":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis"},{"title3":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician"},{"title3":"Identifying age- and sex-specific COVID-19 mortality trends over time in six countries"},{"title3":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility"},{"title3":"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones"},{"title3":"The bi-directional association between loneliness and depression among older adults from before to during the COVID-19 pandemic"},{"title3":"Inflammation: Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling"},{"title3":"Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality"},{"title3":"Acute Cardiac Events During COVID-19-Associated Hospitalizations"},{"title3":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes"},{"title3":"Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic"},{"title3":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition"},{"title3":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Neutrophil extracellular traps in COVID-19. JCI"}]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title3":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure"},{"title3":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology"},{"title3":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease"},{"title3":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice"},{"title3":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure"},{"title3":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020"},{"title3":"Angiotensin blockade in late autosomal dominant polycystic kidney disease"},{"title3":"Hypoalbuminemia in acute illness: is there a rationale for intervention?"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse"},{"title3":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"}]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Physiology of local renin-angiotensin systems."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Pharmacologic modulation of ACE2 expression."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19."},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic."},{"title3":"Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients."},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China."},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19."},{"title3":"Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes."},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial."},{"title3":"Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)."},{"title3":"Coronavirus emergency."},{"title3":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension."},{"title3":"Generating evidence from computerized healthcare utilization databases."},{"title3":"Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs."},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy."}]},{"title2":"Cardiovascular disease, drug therapy, and mortality in Covid-19","References":[]},{"title2":" https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (13 May 2020).","References":[]}]},{"title1":"The characteristics and outcomes of 681 severe cases with COVID-19 in China","References":[{"title2":"A comprehensive literature review on the clinical presentation, and management of the Pandemic Coronavirus Disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica)"},{"title3":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang, China"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Understanding the symptoms of the common cold and influenza"},{"title3":"Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)"},{"title3":"Preliminary clinical description of severe acute respiratory syndrome"},{"title3":"MERS clinical features"},{"title3":"Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Novel coronavirus (COVID-19) situation"},{"title3":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China"},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 is suspected: interim guidance"},{"title3":"Evaluating and testing persons for coronavirus disease 2019 (COVID-19)"},{"title3":"Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Discharge criteria for confirmed COVID-19 cases - When is it safe to discharge COVID-19 cases from the hospital or end home isolation?"},{"title3":"Updated IPAC recommendations for use of personal protective equipment for care of individuals with suspect or confirmed COVID-19"},{"title3":"Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat"},{"title3":"Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome"},{"title3":"The emerging role of vitamin C as a treatment for sepsis"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19): current status and future perspective","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study","References":[]},{"title2":"A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds."},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset."},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome."},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen."},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) home page ()."},{"title3":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection."},{"title3":"Coronavirus disease (COVID-2019) R&amp;D. Geneva: World Health Organization ()."},{"title3":"National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. London: Royal College of Physicians, 2017 ()."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study."},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data."},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09."},{"title3":"Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus."}]},{"title2":"Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome"},{"title3":"The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target"},{"title3":"Mechanisms of COVID-19-induced heart failure: a short review"},{"title3":"The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science"},{"title3":"Mechanisms of COVID-19 pathogenesis in diabetes"},{"title3":"Cardiac iron overload promotes cardiac injury in patients with severe COVID-19"},{"title3":"Sexual dimorphism in COVID-19: potential clinical and public health implications"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects"},{"title3":"Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?"},{"title3":"Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference"},{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Hamidi A and Olsson A K: Platelets, NETs and cancer"},{"title3":"Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"COVID-19 and Cardiovascular Disease: From Bench to Bedside"},{"title3":"A global meta-analysis of depression, anxiety, and stress before and during COVID-19"},{"title3":"COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample Database"},{"title3":"Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic"},{"title3":"COVID-19 and metabolic syndrome"},{"title3":"Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases"},{"title3":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021"},{"title3":"COVID-19, Myocarditis and Pericarditis"},{"title3":"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets"},{"title3":"Cardiometabolic syndrome:an emergent feature of Long COVID?"},{"title3":"Risk factors for severe and critically ill COVID-19 patients: A review"},{"title3":"The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"},{"title3":"Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19"},{"title3":"Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"},{"title3":"Depression and Anxiety in Old Age during the COVID-19 Pandemic: A Comparative Study of Individuals at Cardiovascular Risk and the General Population"},{"title3":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"},{"title3":"Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease"},{"title3":"Association of social relationships with incident cardiovascular events and all-cause mortality"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?"},{"title3":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases"},{"title3":"Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis"},{"title3":"Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review"},{"title3":"SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor"},{"title3":"COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors"},{"title3":"COVID-19 infection and its impact on case fatality in patients with pulmonary embolism"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review"},{"title3":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases"},{"title3":"COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis"},{"title3":"Nationwide Analysis of the Outcomes and Mortality of Hospitalized COVID-19 Patients"},{"title3":"N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients"},{"title3":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"title3":"Cardiovascular manifestations and treatment considerations in COVID-19"},{"title3":"TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation"},{"title3":"Incidence and risk factors of myocarditis in hospitalized patients with COVID-19"},{"title3":"Vascular Endothelial Cell Biology: An Update"},{"title3":"ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review"},{"title3":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2"},{"title3":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States"},{"title3":"Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis"},{"title3":"COVID-19 and cardiovascular diseases"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease"},{"title3":"Gender-based disparities in COVID-19 patient outcomes"},{"title3":"Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19"},{"title3":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients"},{"title3":"Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus"},{"title3":"TMPRSS2 activity may mediate sex differences in COVID-19 severity"},{"title3":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies"},{"title3":"Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19"},{"title3":"Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin"},{"title3":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity"},{"title3":"Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis"},{"title3":"Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury"},{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"COVID-19 and cellular senescence"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Endothelial Cell-Activating Antibodies in COVID-19"},{"title3":"COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19"},{"title3":"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1"},{"title3":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis"},{"title3":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician"},{"title3":"Identifying age- and sex-specific COVID-19 mortality trends over time in six countries"},{"title3":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility"},{"title3":"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones"},{"title3":"The bi-directional association between loneliness and depression among older adults from before to during the COVID-19 pandemic"},{"title3":"Inflammation: Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling"},{"title3":"Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality"},{"title3":"Acute Cardiac Events During COVID-19-Associated Hospitalizations"},{"title3":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes"},{"title3":"Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic"},{"title3":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition"},{"title3":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Neutrophil extracellular traps in COVID-19. JCI"}]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Tuberculosis and diabetes mellitus: convergence of two epidemics"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score"},{"title3":"Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp; Mortality (HIMM) surveillance"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Connecting type 1 and type 2 diabetes through innate immunity"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","References":[]}]}]}